{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:46:18Z","timestamp":1790174778148,"version":"4.1.0"},"reference-count":29,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:p>An open trial to evaluate the azithromycin efficacy in cutaneous leishmaniasis patients was carried out in Manaus (AM), where Leishmania (Viannia) guyanensis is the main etiologic agent. Forty-one patients with skin lesions of less than 12 weeks duration, without specific treatment for the last three months and a positive imprint to Leishmania sp. were included. From these, 31 (75.6%) were male with median age of 30.2. All of them received a daily-single oral dose of 500 mg of azithromycin for ten days. At 25th day, 16 (39%) presented therapeutic failure and received intramuscular pentavalent antimonial, four were considered lost, 21, that had improved or were inaltered received another ten-day series of azithromycin and were monthly followed, but nine (21.9%) of them presented a poor clinical response and switched to intramuscular pentavalent antimonial on day 55. Of the 12 remaining cases evaluated on day 55, despite of clinical improvement, three asked for antimony therapy and 9 (21.9%) continued the follow-up but, only three were cured on 55th, 85th and 115th days, and six did not come back for final evaluation. The intention-treatment overall response rate was 22% and whole cure was seen in three (7.3%) of cases. Thus, azithromycin showed a low efficacy to treat cutaneous leishmaniasis in Manaus.<\/jats:p>","DOI":"10.1590\/s0036-46652007000400008","type":"journal-article","created":{"date-parts":[[2007,10,4]],"date-time":"2007-10-04T16:34:39Z","timestamp":1191515679000},"page":"235-238","source":"Crossref","is-referenced-by-count":10,"title":["Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil"],"prefix":"10.1590","volume":"49","author":[{"given":"Alan C\u00e9sar","family":"Teixeira","sequence":"first","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcilene Gomes","family":"Paes","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o de Medicina Tropical do Amazonas, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge de Oliveira","family":"Guerra","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o de Medicina Tropical do Amazonas, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alu\u00edzio","family":"Prata","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Le\u00f3n","family":"Silva-Vergara","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"ALRAJHI A.A.","year":"2002","journal-title":"New Engl. J. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0035-9203(92)90427-E","article-title":"Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol","volume":"86","author":"ANTEZANA G.","year":"1992","journal-title":"Trans. roy. Soc. trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0020-7519(96)00128-2","article-title":"Itraconazole and leishmaniasis: a randomized double-blind trial in cutaneous disease","volume":"26","author":"DOGRA J.","year":"1996","journal-title":"Int. J. Parasit."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/31.suppl_E.39","article-title":"Selection of dose regimens of azithromycin","volume":"31","author":"FOULDS G.","year":"1993","journal-title":"J. antimicrob. Chemother."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"FOULDS G.","year":"1990","journal-title":"J. antimicrob. Chemother."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jac\/45.4.453","article-title":"Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture","volume":"45","author":"GIACOMETTI A.","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/AAC.31.12.1948","article-title":"Pharmacokinetic and in vivo studies with azithromycin (CP-62, 993), a new macrolide with an extended half-life and excellent tissue distribution","volume":"31","author":"GIRARD A.E.","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4269\/ajtmh.1989.41.687","article-title":"A review of geographic distribution and epidemiology of leishmaniasis in the New World","volume":"41","author":"GRIMALDI Jr. G.","year":"1989","journal-title":"Amer. J. trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0035-9203(94)90432-4","article-title":"Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis","volume":"88","author":"HEPBURN N.C.","year":"1994","journal-title":"Trans. roy. Soc. trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"HERWALDT B.L.","year":"1999","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Antinflammatory activity of macrolide antibiotics","volume":"292","author":"IANARO A.","year":"2000","journal-title":"J. Pharmacol. exp. Ther."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0035-9203(83)90058-5","article-title":"Evaluation of diamidine compound (pentamidine isethionate) in the treatment of resistant cases of kala-azar occurring in North Bihar, India","volume":"77","author":"JHA T.K.","year":"1983","journal-title":"Trans. roy. Soc. trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1128\/AAC.43.12.2869","article-title":"Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients","volume":"43","author":"KOLETAR S.L.","year":"1999","journal-title":"J. Antimicrob. Agents Chemother."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJM200011163432004","article-title":"Atovaquone and azithromycin for the treatment of babesiosis","volume":"343","author":"KRAUSE P.J.","year":"2000","journal-title":"New Engl. J. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.2002.67.273","article-title":"Activity of azithromycin against Leishmania major in vitro and in vivo","volume":"67","author":"KROLEWIECKI A.J.","year":"2002","journal-title":"Amer. J. trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/S0037-86821984000400003","article-title":"Human mucocutaneous leishmaniasis in Tr\u00eas Bra\u00e7os, Bahia - Brazil: An area of Leishmania braziliensis braziliensis transmission. II. Cutaneous disease. Presentation and evolution","volume":"17","author":"LLANOS-CUENTAS E.A.","year":"1984","journal-title":"Rev. Soc. bras. Med. trop.","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1590\/S0037-86821985000300011","article-title":"Pentavalent antimonials: old drugs for new diseases","volume":"18","author":"MARSDEN P.D.","year":"1985","journal-title":"Rev. Soc. bras. Med. trop.","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1016\/0002-9343(91)90395-E","article-title":"Clinical microbiology of azithromycin","volume":"91","author":"NEU H.C.","year":"1991","journal-title":"Amer. J. Med."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0169-4758(93)90231-4","article-title":"Practical progress and new drugs for changing patterns of leishmaniasis","volume":"9","author":"OLLIARO P.L.","year":"1993","journal-title":"Parasit. today","ISSN":"https:\/\/id.crossref.org\/issn\/0169-4758","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2165\/00003495-199244050-00007","article-title":"Azithromycin: A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy","volume":"44","author":"PETERS D.H.","year":"1992","journal-title":"Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/S0037-86822003000100010","article-title":"Efficacy of azithromycin in the treatment of cutaneous leishmaniasis","volume":"36","author":"PRATA A.","year":"2003","journal-title":"Rev. Soc. bras. Med. trop.","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0035-9203(01)90027-6","article-title":"Therapeutic responses to antibacterial drugs in vivax malaria","volume":"95","author":"PUKRITTAYAKAMEE S.","year":"2001","journal-title":"Trans. roy. Soc. trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L.(V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"ROMERO G.A.S.","year":"2001","journal-title":"Amer. J. trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1590\/S0036-46652004000300011","article-title":"Azithromycin in the treatment of mucosal leishmaniasis","volume":"46","author":"SILVA-VERGARA M.L.","year":"2004","journal-title":"Rev. Inst. Med. trop. S. Paulo","ISSN":"https:\/\/id.crossref.org\/issn\/0036-4665","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1086\/322689","article-title":"Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent","volume":"33","author":"SOTO J.","year":"2001","journal-title":"Clin. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"SUNDAR S.","year":"2002","journal-title":"New Engl. J. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref27","first-page":"361","article-title":"Tratamento da leishmaniose tegumentar americana: Resultados preliminares com a pentamidina","volume":"60","author":"TALHARI S.","year":"1985","journal-title":"An. bras. Derm.","ISSN":"https:\/\/id.crossref.org\/issn\/0365-0596","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/AAC.40.1.75","article-title":"Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions","volume":"40","author":"WILDFEUER A.","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1348-0421.1996.tb01097.x","article-title":"Effect of macrolide antibiotics on macrophage functions","volume":"40","author":"XU G.","year":"1996","journal-title":"Microbiol. Immunol."}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v49n4\/a08v49n4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T11:55:00Z","timestamp":1737460500000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652007000400008&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0036-46652007000400008"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46652007000400008","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}